89bio
ETNB
ETNB
145 hedge funds and large institutions have $828M invested in 89bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $1.14B → $828M (-$316M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
89% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $10.8M
Holders
145
Holding in Top 10
2
Calls
$1.24M
Puts
$10.8M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$18.4M | |
| 3 | +$13.9M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$5.39M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$18.4M | |
| 3 | -$5.05M | |
| 4 |
Morgan Stanley
New York
|
-$4.17M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.16M |